Exponent (NASDAQ:EXPO) is gearing up to announce its quarterly earnings on Thursday, 2026-02-05. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Exponent will report an earnings per share (EPS) of $0.47.
The announcement from Exponent is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Performance in Previous Earnings
Last quarter the company beat EPS by $0.03, which was followed by a 5.97% increase in the share price the next day.
Here's a look at Exponent's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.52 | 0.50 | 0.52 | 0.43 |
| EPS Actual | 0.55 | 0.52 | 0.52 | 0.46 |
| Price Change % | 6.00 | -1.00 | -1.00 | 1.00 |
Performance of Exponent Shares
Shares of Exponent were trading at $69.92 as of February 03. Over the last 52-week period, shares are down 21.53%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
Analysts' Perspectives on Exponent
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Exponent.
The consensus rating for Exponent is Neutral, derived from 2 analyst ratings. An average one-year price target of $90.5 implies a potential 29.43% upside.
Peer Ratings Overview
The analysis below examines the analyst ratings and average 1-year price targets of Science Applications Intl, Andersen Group and CBIZ, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
Comprehensive Peer Analysis Summary
The peer analysis summary offers a detailed examination of key metrics for Science Applications Intl, Andersen Group and CBIZ, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.
Key Takeaway:
Exponent ranks at the top for Revenue Growth among its peers. It is in the middle for Gross Profit. Exponent is at the bottom for Return on Equity.
Unveiling the Story Behind Exponent
Exponent's Economic Impact: An Analysis
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Net Margin: Exponent's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 19.06% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Exponent's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 6.75%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Exponent's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.69% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a below-average debt-to-equity ratio of 0.21, Exponent adopts a prudent financial strategy, indicating a balanced approach to debt management.
To track all earnings releases for Exponent visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

